日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Proteomic Profiling of Medullary Thyroid Cancer Identifies CAPN1 as a Key Regulator of NF1 and RET Fueled Growth.

髓样甲状腺癌蛋白质组学分析发现 CAPN1 是 NF1 和 RET 驱动生长的关键调节因子

Khan Eshan, Hylton Hannah, Rajan Neel, Bouley Stephanie J, Siddiqui Jalal K, Rajasekaran Swetha, Koshre Ganesh R, Storts Hayden, Valenciaga Anisley, Khan Misbah, Liyanarachchi Sandya, Fernandez Francisco, Zheng Xuguang, Phay John, Dedhia Priya H, Wang Jing, Walker James A, Ringel Matthew D, Miles Wayne O

Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.

开发一种新型生物标志物平台,用于分析关键蛋白质-蛋白质相互作用,以预测 BH3 模拟药物的疗效

Kinloch Andrew J, Rahman Faiyaz, Karakas Bahriye, Shahid Muhammad, Lim Bora, Bouley Stephanie J, Walker James A, Lee Erinna F, Fairlie Walter D, Kelly Kevin R, Cardone Michael H

Neurofibromatosis Type 1 and the Search for Effective Tumor Therapies Using High-Throughput Drug Screening

1型神经纤维瘤病及利用高通量药物筛选寻找有效肿瘤疗法

Bouley, Stephanie J; Housden, Benjamin E; Walker, James A

High-content microscopy and machine learning characterize a cell morphology signature of NF1 genotype in Schwann cells

高内涵显微镜和机器学习技术揭示了雪旺细胞中NF1基因型的细胞形态特征

Tomkinson, Jenna; Mattson, Cameron; Mattson-Hoss, Michelle; Sarnoff, Herb; Bouley, Stephanie J; Walker, James A; Way, Gregory P

Combined Inhibition of Both p110α and p110β Isoforms of Phosphatidylinositol 3-Kinase Is Required for Sustained Therapeutic Effect in PTEN-Deficient, ER(+) Breast Cancer

在PTEN缺陷型ER(+)乳腺癌中,同时抑制磷脂酰肌醇3-激酶的p110α和p110β两种亚型是维持治疗效果所必需的。

Hosford, Sarah R; Dillon, Lloye M; Bouley, Stephanie J; Rosati, Rachele; Yang, Wei; Chen, Vivian S; Demidenko, Eugene; Morra, Rocco P Jr; Miller, Todd W